# Irinotecan, Vincristine, and Dexamethasone In Children With Relapsed And/Or Refractory Hematologic Malignancies

> **NCT00718757** · PHASE1 · COMPLETED · sponsor: **St. Jude Children's Research Hospital** · enrollment: 4 (actual)

## Conditions studied

- Non-Hodgkins Lymphoma
- Hodgkin's Disease
- Acute Lymphoblastic Leukemia

## Interventions

- **DRUG:** Dexamethasone
- **DRUG:** Irinotecan
- **DRUG:** Vincristine

## Key facts

- **NCT ID:** NCT00718757
- **Lead sponsor:** St. Jude Children's Research Hospital
- **Sponsor class:** OTHER
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2005-01
- **Primary completion:** 2009-01
- **Final completion:** 2009-01
- **Target enrollment:** 4 (ACTUAL)
- **Last updated:** 2013-08-28


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00718757

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00718757, "Irinotecan, Vincristine, and Dexamethasone In Children With Relapsed And/Or Refractory Hematologic Malignancies". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT00718757. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*